Multifunctional magnetoliposomes as drug delivery vehicles for the potential treatment of Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. Therefore, development of novel technologies and strategies to treat PD is a global health priority. Current treatments include administration of Levodopa, monoamine oxidase inhibitors, catechol-...

Full description

Bibliographic Details
Main Authors: Javier Cifuentes, Santiago Cifuentes-Almanza, Paola Ruiz Puentes, Valentina Quezada, Andrés Fernando González Barrios, María-Angélica Calderón-Peláez, Myriam Lucia Velandia-Romero, Marjan Rafat, Carolina Muñoz-Camargo, Sonia L. Albarracín, Juan C. Cruz
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1181842/full